What it sells
AI-enabled, clinical-stage biotech building a development engine for precision oncology using multimodal data, biological modeling and biopharma partnerships.
Business model breakdown
Distribution: how it reaches customers
Biopharma partnerships ("Partner With Us").
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-24 | Series E | $237M | — | news.google.com |
| 2026-10-23 | Series E | $237M | Bristol Myers Squibb (lead) | news.google.com |
| 2026-10-23 | Series E | $237M | — | pulse2.com |
| 2026-10-23 | — | $237M | — | siliconangle.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-29.